BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16140376)

  • 1. Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis.
    Ogura K; Kimura F; Kobayashi S; Torikai H; Ikeda T; Sato K; Motoyoshi K
    Leuk Res; 2006 Jun; 30(6):761-3. PubMed ID: 16140376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CD7(+) acute myeloid leukemia (M0) associated with a mediastinal bulky mass lesion].
    Yoshida K; Kusumoto S; Sugahara Y; Yagasaki F; Sakata T; Kawai N; Matsuda A; Suzuki T; Hirashima K; Kayano H; Bessho M
    Rinsho Ketsueki; 2001 Aug; 42(8):644-9. PubMed ID: 11579505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias.
    Cruse JM; Lewis RE; Pierce S; Lam J; Tadros Y
    Exp Mol Pathol; 2005 Aug; 79(1):39-41. PubMed ID: 16005710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelated donor bone marrow transplantation for acute mixed lineage (myeloid and B-lymphoid lineage) leukemia in an adult with Down syndrome.
    Takagi K; Yoshida A; Kinoshita K; Iwashima D; Imamaura S; Iwasaki H; Tsutani H; Ueda T
    Ann Hematol; 2003 Apr; 82(4):236-40. PubMed ID: 12707727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duplication of isodicentric chromosome 21, idic(21)(p11.2), leading to pentasomy 21q in acute myeloid leukemia with multilineage dysplasia.
    Shimoyama M; Yamamoto K; Nishikawa S; Minagawa K; Katayama Y; Matsui T
    Cancer Genet Cytogenet; 2009 Oct; 194(1):38-43. PubMed ID: 19737652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19.
    Mizutani M; Miwa H; Takahashi T; Katoh K; Shikami M; Katayama N; Shiku H; Kita K
    Int J Hematol; 1997 Dec; 66(4):479-91. PubMed ID: 9479874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid/natural killer cell precursor acute leukemia with tetraploidy.
    Dinçol G; Palandüz S; Nalçaci M; Uçur A; Büyükaydin B
    Cancer Genet Cytogenet; 2005 Dec; 163(2):156-9. PubMed ID: 16337859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
    Schulze A; Schirutschke H; Oelschlägel U; Schmitz M; Füssel M; Wassmuth R; Ehninger G; Bornhäuser M; Platzbecker U
    Exp Hematol; 2008 Apr; 36(4):378-89. PubMed ID: 18261840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute undifferentiated leukemia with an unusual CD7+ CD56+ CD33+ immunophenotype of NK progenitors.
    Reuss-Borst MA; Jaschonek K; Müller CA
    Leukemia; 1996 May; 10(5):923-4. PubMed ID: 8656693
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myeloid/natural killer cell precursor acute leukemia diagnosed by cell marker analysis].
    Miura R; Yoshimi M; Kikuchi Y; Takahashi T
    Rinsho Ketsueki; 2013 Jun; 54(6):579-83. PubMed ID: 23823098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood myeloid/natural killer precursor acute leukemia with novel chromosomal aberrations der(5)t(4;5)(q31;q31.3) and t(14;17)(q32;q23).
    Abdelhaleem M; Shago M; Sayeh E; Abla O
    Cancer Genet Cytogenet; 2007 Oct; 178(2):141-3. PubMed ID: 17954270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
    Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M
    Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CD33-positive acute lymphoblastic leukemia with breast tumor and cavernous sinus tumor].
    Ishida T; Yoshimoto M; Ono A; Saitoh N; Nakano T; Higashide T; Sugiyama T; Hinota Y; Imai K; Yachi A
    Rinsho Ketsueki; 1989 Dec; 30(12):2194-8. PubMed ID: 2621803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
    Nakase K; Kita K; Miwa H; Nishii K; Shiku H; Nasu K; Dohy H; Kyo T; Kamada N; Tsutani H
    Cancer Detect Prev; 2001; 25(4):394-405. PubMed ID: 11531016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia.
    Kraguljac N; Marisavljevic D; Jankovic G; Radosevic N; Pantic M; Donfrid M; Miletic N; Boskovic D; Colovic M
    Am J Clin Pathol; 2000 Jul; 114(1):29-34. PubMed ID: 10884796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
    Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
    Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias.
    Suggs JL; Cruse JM; Lewis RE
    Exp Mol Pathol; 2007 Dec; 83(3):471-3. PubMed ID: 17963747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.